141.35
前日終値:
$157.14
開ける:
$156.97
24時間の取引高:
1.01M
Relative Volume:
2.75
時価総額:
$9.33B
収益:
$3.55B
当期純損益:
$370.24M
株価収益率:
25.79
EPS:
5.48
ネットキャッシュフロー:
$355.96M
1週間 パフォーマンス:
-12.20%
1か月 パフォーマンス:
-11.11%
6か月 パフォーマンス:
-10.05%
1年 パフォーマンス:
-3.86%
Aptargroup Inc Stock (ATR) Company Profile
ATR を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ATR
Aptargroup Inc
|
141.35 | 10.38B | 3.55B | 370.24M | 355.96M | 5.48 |
![]()
ISRG
Intuitive Surgical Inc
|
483.12 | 172.46B | 9.15B | 2.61B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
176.37 | 51.09B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.87 | 43.30B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
279.20 | 39.87B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
239.26 | 17.20B | 2.90B | 467.20M | 306.90M | 6.37 |
Aptargroup Inc Stock (ATR) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-01-07 | 開始されました | Raymond James | Outperform |
2025-01-06 | ダウングレード | BofA Securities | Buy → Neutral |
2024-10-14 | アップグレード | Jefferies | Hold → Buy |
2024-04-29 | アップグレード | William Blair | Mkt Perform → Outperform |
2024-01-03 | アップグレード | Robert W. Baird | Neutral → Outperform |
2021-08-02 | ダウングレード | William Blair | Outperform → Mkt Perform |
2021-04-14 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-10-14 | 開始されました | Seaport Global Securities | Neutral |
2020-04-27 | アップグレード | BofA/Merrill | Neutral → Buy |
2020-03-25 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2020-03-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2020-02-26 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2019-07-08 | 開始されました | Morgan Stanley | Overweight |
2019-04-05 | 繰り返されました | BofA/Merrill | Underperform |
2019-02-27 | アップグレード | Robert W. Baird | Neutral → Outperform |
2018-05-18 | 開始されました | Jefferies | Hold |
2016-12-07 | ダウングレード | BofA/Merrill | Buy → Underperform |
2016-10-13 | 開始されました | Jefferies | Hold |
2016-01-05 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2015-11-02 | アップグレード | Deutsche Bank | Hold → Buy |
2015-09-15 | アップグレード | BofA/Merrill | Neutral → Buy |
2015-05-01 | アップグレード | BofA/Merrill | Underperform → Neutral |
2013-02-19 | 繰り返されました | Deutsche Bank | Hold |
2013-01-08 | アップグレード | Robert W. Baird | Neutral → Outperform |
2012-07-10 | ダウングレード | KeyBanc Capital Mkts | Buy → Hold |
2012-04-11 | 開始されました | KeyBanc Capital Mkts | Buy |
2011-06-13 | アップグレード | KeyBanc Capital Mkts | Hold → Buy |
すべてを表示
Aptargroup Inc (ATR) 最新ニュース
Is it the right time to buy AptarGroup Inc. stockBuild a portfolio that stands the test of time - jammulinksnews.com
How strong is AptarGroup Inc. company’s balance sheetExtraordinary market timing - jammulinksnews.com
Is AptarGroup Inc. stock overvalued or undervaluedGet exclusive access to professional stock picks - jammulinksnews.com
What are the latest earnings results for AptarGroup Inc.Get daily updates on market movers and shakers - jammulinksnews.com
Does AptarGroup Inc. stock perform well during market downturnsExceptional return forecasts - jammulinksnews.com
What catalysts could drive AptarGroup Inc. stock higher in 2025Jaw-dropping returns - jammulinksnews.com
AptarGroup's 2025 Q2 Earnings and Strategic Positioning: Navigating Supply Chain Shifts While Delivering Sustainable Growth - AInvest
AptarGroup, Inc. (NYSE:ATR) Q2 2025 Earnings Call Transcript - Insider Monkey
AptarGroup's Q3 Earnings Outlook: Navigating Legal and Market Headwinds While Maintaining Growth Momentum - AInvest
AptarGroup Inc (ATR) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansions ... - Yahoo Finance
AptarGroup (ATR): Navigating Short-Term Headwinds to Unlock Long-Term Growth in Pharma Innovation - AInvest
AptarGroup Inc (ATR) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansions ... By GuruFocus - Investing.com Canada
AptarGroup Reports Strong Q2 2025 Results - TipRanks
SWK Holdings Finalizes Asset Sale to AptarGroup - MSN
AptarGroup Earnings Call: Pharma and Closures Shine - TipRanks
AptarGroup (ATR) Q2 Revenue Rises 6% - The Motley Fool
AptarGroup expects Q3 adjusted EPS of $1.53–$1.61 while navigating inventory headwinds and litigation costs - MSN
AptarGroup's Q2 2025: Unpacking Contradictions in Pharma Growth, Legal Costs, and Beauty Segment Challenges - AInvest
Research Alert: Aptargroup Posts 15th Consecutive Eps Beat With Accelerating Margin Expansion - 富途牛牛
What is AptarGroup Inc. company’s growth strategySmart Portfolio Recommendation For Beginners - jammulinksnews.com
AptarGroup Q2 2025 Earnings Preview - MSN
Aptar Launches Bio-based Nasal Spray Packaging Solution - PlasticsToday
APTARGROUP, INC. SEC 10-Q Report - TradingView
Earnings call transcript: AptarGroup Q2 2025 beats EPS forecast, shares dip By Investing.com - Investing.com South Africa
Earnings call transcript: AptarGroup Q2 2025 beats EPS forecast, shares dip - Investing.com Australia
What are the technical indicators suggesting about AptarGroup Inc.Stock Strategy Trend Scanner To Watch Now - jammulinksnews.com
How does AptarGroup Inc. compare to its industry peersExpert Picks Data Feed From AI Tools - jammulinksnews.com
AptarGroup Surpasses Q2 Earnings Forecasts with Strong PerformanceNews and Statistics - IndexBox
AptarGroup Lifts Sales And Profit On Pharma Demand In Q2 - Finimize
AptarGroup: Q2 Earnings Snapshot - CTPost
AptarGroup Q2 2025 slides: All segments deliver growth, margins expand By Investing.com - Investing.com South Africa
Is this a good reentry point in AptarGroup Inc.Trade Ready Stock Watch for Short Term Published - metal.it
Aptargroup Inc reports results for the quarter ended June 30Earnings Summary - TradingView
AptarGroup (ATR) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Aptar Reports Second Quarter 2025 Results - Aptar
AptarGroup, Inc. Reports Second Quarter 2025 Results - TradingView
Aptar Q2 2025: Reported sales up 6%, net income up 24%, EBITDA up 13%. - AInvest
AptarGroup Earnings Reveal 25% Profit Jump: Biologics and GLP-1 Drive Record Quarter Results - Stock Titan
The total return for AptarGroup (NYSE:ATR) investors has risen faster than earnings growth over the last three years - Yahoo.co
Zacks Industry Outlook Highlights Brambles, AptarGroup and Greif - Yahoo Finance
What To Expect From AptarGroup Inc (ATR) Q2 2025 Earnings - Yahoo Finance
AptarGroup: Maintaining Stability Ahead of Q2 Earnings - AInvest
AptarGroup: Holding Steady Until Q2 Results - Seeking Alpha
AptarGroup Inc (ATR) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
AptarGroup Inc. Stock Lags Behind Sector BenchmarksEntry Alert Based on Volume Spikes Detected - metal.it
What makes AptarGroup Inc. stock price move sharplyEntry and Exit Strategy Optimizer Tool Tested - metal.it
How high can AptarGroup Inc. stock price go in 2025Watchlist for Low Risk High Return Stocks Updated - metal.it
Aptar’s First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon’s Otrivin® Brand - StreetInsider
Aptar Revolutionizes Pharma Packaging: First-Ever 52% Bio-based Nasal Pump Debuts in Otrivin Products - Stock Titan
Aptargroup ATR Q2 2025 Earnings Preview Upside Potential on Expected Revenue Growth - AInvest
AptarGroup (ATR): The Unsung Hero of Reliable Dividend Growth - MSN
Aptargroup Inc (ATR) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):